And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...
The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.